Valneva reports 1H results; reaffirms FY outlook
Source: SeekingAlpha
2025-08-12 01:07:56 ET
More on Valneva
- FDA lifts pause on Valneva's chikungunya vaccine in elderly
- CDC mulls travel notice for China amid rise in chikungunya cases
- Seeking Alpha’s Quant Rating on Valneva
- Historical earnings data for Valneva
- Financial information for Valneva
Read the full article on Seeking Alpha
For further details see:
Valneva reports 1H results; reaffirms FY outlook
Valneva SE
NASDAQ: VALN
VALN Trading
0.48% G/L:
$10.57 Last:
819 Volume:
$10.60 Open:
VALN Latest News
March 18, 2026 08:00:00 am
Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program
VALN Stock Data
$798,793,290
73,508,485
N/A
10
N/A
Biotechnology & Life Sciences
Healthcare
FR
Lyon
